SABBY MANAGEMENT LLC 13D and 13G filings for Titan Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-01-03 4:43 pm Sale | 2021-12-31 | 13G | Titan Pharmaceuticals, Inc. TTNP | SABBY MANAGEMENT LLC | 24,736 11.000% | -9,327 (-27.38%) | Filing |
| 2021-01-22 11:58 am Purchase | 2021-01-15 | 13G | Titan Pharmaceuticals, Inc. TTNP | SABBY MANAGEMENT LLC | 34,063 11.000% | 22,685 (+199.38%) | Filing |
| 2021-01-07 10:00 am Purchase | 2020-12-31 | 13G | Titan Pharmaceuticals, Inc. TTNP | SABBY MANAGEMENT LLC | 11,378 11.000% | 11,378 (New Position) | Filing |